Pricing Log in Create free account
Saturday 17 October 2026 Export IDXX’s income statement to Excel — free account

IDEXX Laboratories, Inc.

IDXX Healthcare Diagnostics & Research

IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.66%, EPS grew 17.2%, free cash flow grew 111.4% and total debt fell 14.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three.

560.36 13.18 +2.41%
Market cap
$43.1B
P/E
39.1×
Fwd P/E
38.3×
Dividend yield
—
F-score
8/9
Altman Z
24.09
Beneish M
−2.50
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

IDEXX Laboratories, Inc. (IDXX) Piotroski F-score

Alert me on Piotroski F-score

IDEXX Laboratories, Inc.'s Piotroski F-score for fiscal 2025 is 8 out of 9: 8 of nine tests of profitability, leverage and efficiency passed, up from 6 in fiscal 2024.

Piotroski F-score, annual

Embed this chart

Annual newest first

Period Piotroski F-score Change (points)
FY2025 8 2.00
FY2024 6 (2.00)
FY2023 8 3.00
FY2022 5 (3.00)
FY2021 8 1.00
FY2020 7 (1.00)
FY2019 8 0.00
FY2018 8 (1.00)
FY2017 9 2.00
FY2016 7 —

How fiscal 2025’s score is made up

Test This year Year before Result Points
Positive return on assets 31.89% 27.10% Pass 1
Positive operating cash flow 1.18b 929.00m Pass 1
Rising return on assets 31.89% 27.10% Pass 1
Cash flow above net income 122.34m 41.13m Pass 1
Falling long-term leverage 0.11 0.14 Pass 1
Rising current ratio 1.23 1.31 Fail 0
No new shares issued 80,427,000 82,467,000 Pass 1
Rising gross margin 61.80% 61.04% Pass 1
Rising asset turnover 1.30 1.19 Pass 1
Piotroski F-score Strong — most fundamentals improved 8

How the Piotroski F-score works

One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.

Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:

7–9Strong — most fundamentals improved
4–6Mixed
0–3Weak — most fundamentals deteriorated

Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.

Piotroski F-score against peers

Company Piotroski F-score
DGX Quest Diagnostics Incorporated compare 8
ILMN Illumina, Inc. compare 8
LH Labcorp Holdings Inc. compare 8
IDXX IDEXX Laboratories, Inc. 8
NTRA Natera, Inc. compare 6
MTD Mettler-Toledo International, Inc. compare 5
WAT Waters Corporation compare 5
A Agilent Technologies, Inc. compare 5
IQV IQVIA Holdings Inc. compare 4

What Piotroski F-score is

The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.

One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover

The full definition of Piotroski F-score →

More on IDXX